drugset / Trial / NCT01429987
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to placebo in patients with Chronic Idiopathic Constipation (CIC).
Timeline
- Start
- 2011-10
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Plecanatide | Peptide | 0.3 mg | Oral |
| Subject | Plecanatide | Peptide | 1 mg | Oral |
| Subject | Plecanatide | Peptide | 3 mg | Oral |